| Kyle Kallenbach, MD | |
|
430 Pennsylvania Ave, Glen Ellyn, IL 60137-4464 | |
| (630) 469-9200 | |
| Not Available |
| Full Name | Kyle Kallenbach |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 28 Years |
| Location | 430 Pennsylvania Ave, Glen Ellyn, Illinois |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1477529626 | NPI | - | NPPES |
| 036105204 | Medicaid | IL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | 036105204 (Illinois) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Dupage Medical Group Ltd | 5496667941 | 1209 |
| The South Bend Clinic Llc | 3779577937 | 174 |
News Archive
Scientists have just discovered how the engine that powers cancer-killing cells functions. Crucially, their research also highlights how that engine is fuelled and that cholesterol-like molecules, called oxysterols, act as a "cut-off" switch making it hard for our 'Natural Killer' cells to win the war against cancer.
A new, personalized and noninvasive treatment using 3-D printed implants has been developed to help children born with abnormally small or missing eyes.
Response Biomedical Corporation today announced that Roche Diagnostics has terminated, effective September 30, 2011, the sales and distribution agreement between Roche and Response dated June 25, 2008. Under the terms of that agreement and related agreements, Roche Diagnostics had agreed to distribute Response's cardiovascular point-of-care (POC) tests on the RAMP® 200 Reader in the US.
A new study indicates that individuals with kidney disease have a higher risk of developing atrial fibrillation, or an irregular heartbeat.
› Verified 4 days ago
| Entity Name | Dupage Medical Group Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801833983 PECOS PAC ID: 5496667941 Enrollment ID: O20031110000535 |
News Archive
Scientists have just discovered how the engine that powers cancer-killing cells functions. Crucially, their research also highlights how that engine is fuelled and that cholesterol-like molecules, called oxysterols, act as a "cut-off" switch making it hard for our 'Natural Killer' cells to win the war against cancer.
A new, personalized and noninvasive treatment using 3-D printed implants has been developed to help children born with abnormally small or missing eyes.
Response Biomedical Corporation today announced that Roche Diagnostics has terminated, effective September 30, 2011, the sales and distribution agreement between Roche and Response dated June 25, 2008. Under the terms of that agreement and related agreements, Roche Diagnostics had agreed to distribute Response's cardiovascular point-of-care (POC) tests on the RAMP® 200 Reader in the US.
A new study indicates that individuals with kidney disease have a higher risk of developing atrial fibrillation, or an irregular heartbeat.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kyle Kallenbach, MD Po Box 713260, Chicago, IL 60677-1260 Ph: (630) 469-9200 | Kyle Kallenbach, MD 430 Pennsylvania Ave, Glen Ellyn, IL 60137-4464 Ph: (630) 469-9200 |
News Archive
Scientists have just discovered how the engine that powers cancer-killing cells functions. Crucially, their research also highlights how that engine is fuelled and that cholesterol-like molecules, called oxysterols, act as a "cut-off" switch making it hard for our 'Natural Killer' cells to win the war against cancer.
A new, personalized and noninvasive treatment using 3-D printed implants has been developed to help children born with abnormally small or missing eyes.
Response Biomedical Corporation today announced that Roche Diagnostics has terminated, effective September 30, 2011, the sales and distribution agreement between Roche and Response dated June 25, 2008. Under the terms of that agreement and related agreements, Roche Diagnostics had agreed to distribute Response's cardiovascular point-of-care (POC) tests on the RAMP® 200 Reader in the US.
A new study indicates that individuals with kidney disease have a higher risk of developing atrial fibrillation, or an irregular heartbeat.
› Verified 4 days ago
Dr. Lekshmi Nair, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 430 Pennsylvania Ave # 110, Glen Ellyn, IL 60137 Phone: 630-946-2020 | |
Mary Lyn Kurland, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 430 Pennsylvania Ave, Glen Ellyn, IL 60137 Phone: 630-469-9200 | |
Dr. Ehsan Safari, D.O. Radiology Medicare: Accepting Medicare Assignments Practice Location: 430 Pennsylvania Ave, 110, Glen Ellyn, IL 60137 Phone: 630-545-7880 | |
Kimberly Klinger, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 430 Pennsylvania Ave Ste 110, Glen Ellyn, IL 60137 Phone: 630-946-2020 Fax: 630-432-6754 | |
Linda Gruener, DO Radiology Medicare: Accepting Medicare Assignments Practice Location: 430 Pennsylvania Ave, Glen Ellyn, IL 60137 Phone: 630-469-9200 | |
Sabira Khalil, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 430 Pennsylvania Ave, Glen Ellyn, IL 60137 Phone: 630-469-9200 |